Stay updated on IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Sign up to get notified when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.

Latest updates to the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe website footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry labeled v3.7.0 has been added to the Record History, and the previous revision v3.6.6 was removed from the list.SummaryDifference0.1%

- Check55 days agoChange DetectedA new study record version, Revision: v3.6.6, was added to the history. The previous version, Revision: v3.6.5, was removed from the sequence.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history section now shows a new revision label (v3.6.5) in place of the previous (v3.6.4), indicating a small page-level update.SummaryDifference0.1%

- Check91 days agoChange DetectedThe study record history shows the revision label updated from v3.6.3 to v3.6.4, signaling a system/software release. This update does not pertain to the study content or data.SummaryDifference0.1%

Stay in the know with updates to IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.